30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

SI-BONE Receives 510(k) Clearance on Updated Indication for iFuse Implant -

SI-BONE received FDA 510(k) clearance of a modified indication for the iFuse Implant System®, noting that clinical studies have demonstrated its ability to improve pain, patient function and quality of life. The revised indication is based on safety and effectiveness data from retrospective studies as well as three prospective clinical trials.

To date, >21,000 iFuse procedures have been performed worldwide to treat sacroiliac joint dysfunction.

Sources: SI-BONE, Inc.; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.